Production (Stage)
Galectin Therapeutics Inc.
GALT
$1.34
$0.021.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.43M | 15.12M | 27.06M | 25.60M | 23.56M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.85M | 1.03M | 1.61M | 1.69M | 1.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.11M | -- | -- | -- |
| Total Current Assets | 9.29M | 17.25M | 28.67M | 27.29M | 25.46M |
|
|
|||||
| Total Current Assets | 9.29M | 17.25M | 28.67M | 27.29M | 25.46M |
| Net Property, Plant & Equipment | 66.00K | 16.00K | 26.00K | 35.00K | 45.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 177.00K | 227.00K | 280.00K | 333.00K | 385.00K |
| Total Assets | 9.53M | 17.50M | 28.97M | 27.66M | 25.89M |
|
|
|||||
| Total Accounts Payable | 6.53M | 5.66M | 2.80M | 3.70M | 3.80M |
| Total Accrued Expenses | 6.83M | 8.19M | 11.55M | 10.81M | 8.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 97.48M | 21.14M | 10.55M | 44.00K | 48.00K |
| Total Finance Division Other Current Liabilities | -- | 432.00K | 359.00K | 63.00K | -- |
| Total Other Current Liabilities | -- | 432.00K | 359.00K | 63.00K | -- |
| Total Current Liabilities | 110.84M | 35.41M | 25.26M | 14.62M | 12.63M |
|
|
|||||
| Total Current Liabilities | 110.84M | 35.41M | 25.26M | 14.62M | 12.63M |
| Long-Term Debt | 10.95M | 85.11M | 94.04M | 93.42M | 84.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | 7.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 47.00K | 2.16M | 1.76M | -- |
| Total Liabilities | 121.79M | 120.57M | 121.45M | 109.80M | 96.98M |
|
|
|||||
| Common Stock & APIC | 296.69M | 296.28M | 294.84M | 293.93M | 292.56M |
| Retained Earnings | -411.18M | -401.57M | -389.54M | -378.30M | -365.87M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -114.48M | -105.29M | -94.70M | -84.37M | -73.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.22M | 2.22M | 2.22M | 2.22M | 2.22M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.22M | 2.22M | 2.22M | 2.22M | 2.22M |
|
|
|||||
| Total Common Equity | -114.48M | -105.29M | -94.70M | -84.37M | -73.31M |
| Total Preferred Equity | 2.22M | 2.22M | 2.22M | 2.22M | 2.22M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -112.26M | -103.07M | -92.48M | -82.15M | -71.09M |
|
|
|||||